• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病中对氧磷酶1的研究。

Study on paraoxonase 1 in type 2 diabetes mellitus.

作者信息

Jamuna Rani A, Mythili S V, Nagarajan Shunmugam

出版信息

Indian J Physiol Pharmacol. 2014 Jan-Mar;58(1):13-6.

PMID:25464671
Abstract

Type 2 Diabetes Mellitus (T 2 D M) occurring as a result of reduced insulin action, is seen in a larger section of population. It is also a condition of Oxidative Stress utilizing the antioxidant resources of the body. One such antioxidant is the Paraoxonasel (PON1) enzyme associated with High Density Lipoprotein. So, the activity of PON1 may be reduced in T 2 D M. Hence, this study was taken up to analyze the status of PON I activity in patients with Type 2 Diabetes Mellitus, attending the Diabetic OP of Sree Balaji Medical College and Hospital (SBMCH). The study included 93 Type 2 Diabetic patients and 89 age and sex matched healthy controls. Paraoxonase 1 activity was assayed by Fluorimetry using the Invitrogen Molecular probes kit. There was a significant reduction in PON1 activity (p value > 0.001) along with a decrease in HDL cholesterol among the Type 2 D M patients compared to healthy controls. The progression of Diabetes Mellitus through the years reflected in a much more reduction in PON1 activity as shown by the Pearsons' correlation analysis. The results were analyzed using SPSS statistical package. It is concluded that Type 2 D M being a condition of Oxidative stress has resulted in the reduction of the antioxidant activity of enzyme PON1.

摘要

2型糖尿病(T2DM)是由于胰岛素作用降低所致,在较大一部分人群中可见。它也是一种利用体内抗氧化资源的氧化应激状态。一种这样的抗氧化剂是与高密度脂蛋白相关的对氧磷酶1(PON1)酶。因此,T2DM患者中PON1的活性可能降低。因此,本研究旨在分析在斯里·巴拉吉医学院和医院(SBMCH)糖尿病门诊就诊的2型糖尿病患者中PON1活性的状况。该研究包括93名2型糖尿病患者和89名年龄和性别匹配的健康对照者。使用Invitrogen分子探针试剂盒通过荧光法测定对氧磷酶1活性。与健康对照者相比,2型糖尿病患者中PON1活性显著降低(p值>0.001),同时高密度脂蛋白胆固醇降低。多年来糖尿病的进展反映在PON1活性的更大程度降低上,如皮尔逊相关性分析所示。使用SPSS统计软件包分析结果。得出的结论是,2型糖尿病作为一种氧化应激状态导致了对氧磷酶1酶的抗氧化活性降低。

相似文献

1
Study on paraoxonase 1 in type 2 diabetes mellitus.2型糖尿病中对氧磷酶1的研究。
Indian J Physiol Pharmacol. 2014 Jan-Mar;58(1):13-6.
2
Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.印度西北部患有冠状动脉疾病和2型糖尿病的旁遮普人的对氧磷酶(PON1)活性
Indian J Med Res. 2007 Jun;125(6):783-7.
3
Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.阿托伐他汀对伴或不伴肾病的 2 型埃及糖尿病患者对氧磷酶 1 活性的调节作用。
J Diabetes Complications. 2010 Sep-Oct;24(5):325-33. doi: 10.1016/j.jdiacomp.2009.04.001. Epub 2009 Jun 23.
4
Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.西北印度人群 2 型糖尿病患者血清对氧磷酶-1(PON1)活性(PONase/AREase)和多态性。
Gene. 2011 Nov 1;487(1):88-95. doi: 10.1016/j.gene.2011.07.011. Epub 2011 Jul 26.
5
High-density lipoprotein composition and paraoxonase activity in Type I diabetes.I型糖尿病患者的高密度脂蛋白组成与对氧磷酶活性
Clin Sci (Lond). 2001 Dec;101(6):659-70.
6
Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.土耳其非胰岛素依赖型糖尿病患者对氧磷酶55和192多态性及其与血清对氧磷酶活性和血脂的关系
Cell Biochem Funct. 2004 May-Jun;22(3):163-8. doi: 10.1002/cbf.1070.
7
Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.2型糖尿病患者血清中的对氧磷酶/芳基酯酶
Acta Pharm. 2006 Mar;56(1):59-68.
8
Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.II型糖尿病并发视网膜病变时对氧磷酶活性降低。
Clin Sci (Lond). 2000 Mar;98(3):355-63.
9
Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes.低人对氧磷酶可预测日本2型糖尿病患者的心血管事件。
Acta Diabetol. 2009 Sep;46(3):239-42. doi: 10.1007/s00592-008-0066-3. Epub 2008 Oct 2.
10
Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients.吸烟与2型糖尿病患者血清抗氧化酶对氧磷酶水平降低有关。
Diabet Med. 2004 May;21(5):423-7. doi: 10.1111/j.1464-5491.2004.01163.x.

引用本文的文献

1
Associations between myeloperoxidase and paraoxonase-1 and type 2 diabetes in patients with ischemic heart disease.在缺血性心脏病患者中,髓过氧化物酶和对氧磷酶-1 与 2 型糖尿病之间的关系。
BMC Cardiovasc Disord. 2022 Dec 3;22(1):521. doi: 10.1186/s12872-022-02928-8.
2
Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer.对氧磷酶-1和五聚素-3在子宫内膜癌诊断和预后中的评估
Antioxidants (Basel). 2022 Oct 13;11(10):2024. doi: 10.3390/antiox11102024.
3
Punicalagin Decreases Serum Glucose Levels and Increases PON1 Activity and HDL Anti-Inflammatory Values in Balb/c Mice Fed a High-Fat Diet.
单宁酸降低高脂饮食喂养的 Balb/c 小鼠的血清血糖水平并增加 PON1 活性和 HDL 的抗炎作用。
Oxid Med Cell Longev. 2018 Jul 31;2018:2673076. doi: 10.1155/2018/2673076. eCollection 2018.
4
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.对氧磷酶(PON)-1:关于遗传学、结构、多态性及临床相关性的简要概述
Vasc Health Risk Manag. 2018 Jun 18;14:137-143. doi: 10.2147/VHRM.S165173. eCollection 2018.
5
Low serum paraoxonase1 activity levels predict coronary artery disease severity.血清对氧磷酶1活性水平低预示冠状动脉疾病的严重程度。
Oncotarget. 2017 Mar 21;8(12):19443-19454. doi: 10.18632/oncotarget.14305.